Osimertinib
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Orlistat Overcoming Third-generation EGFR-TKI Resistance (NCT06818955) | Ping Peng | 2025-02-16 |
| Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC (NCT05458726) | Peking Union Medical College | 2020-09-15 |
| Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases (NCT07491211) | Fudan University | 2019-07-19 |
Track Osimertinib automatically
Every clearance here is in the API, with alerts when new ones post.